Abstract
At laboratory scale, several methods for the purification of immunoglobulins from plasma or serum are available. However, not all of them are equally applicable when the scale-up to the level of the pharmaceutical industry is intended. In this case, among other factors, it must be taken into account the performance and the cost and quality of the end product. Here we present a method of purification based on the differential precipitation of plasma proteins with caprylic acid in a single step that is simple and cheap and can be easily scaled up. This methodology has been successfully applied to the development and production of pharmaceutical product, such as therapeutic antisera where immunoglobulin fraction is the unique active pharmaceutical ingredient.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McKinney MM, Parkinson A (1987) A simple, non-chromatographic procedure to purify immunoglobulins from serum and ascites fluid. J Immunol Methods 96:271–278
Theakston RDG, Warrell DA, Griffiths E (2003) Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 41:541–557
León G, Lomonte B, Gutiérrez JM (2005) Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols. Toxicon 45:123–128
Morais V, Massaldi H (2005) Effect of pepsin digestion on the antivenom activity of equine immunoglobulins. Toxicon 46:876–882
Otero R, León G, Gutiérrez JM et al (2006) Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without β-propiolactone, in the treatment of Bothrops asper bites in Colombia. Trans R Soc Trop Med Hyg 100:1173–1182
Burnouf T, Griffiths E, Padilla A et al (2004) Assessment of the viral safety of antivenoms fractionated from equine plasma. Biologicals 32:115–128
Chanutin A, Curnish RR (1960) The precipitation of plasma proteins by short-chain fatty acids. Arch Biochem Biophys 89:218–220
Steimbuch M, Audran R (1969) The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch Biochem Biophys 134:279–284
Rojas G, Jimenez JM, Gutierrez JM (1994) Caprylic acid fractionation of hyperimmune horse plasma: description of a single procedure for antivenom production. Toxicon 32:351–363
Raweerith R, Ratanabanangkoon K (2003) Fractionation of equine antivenom using caprylic acid precipitation in combination with cationic ion-exchange chromatography. J Immunol Methods 282:63–72
Morais V, Massaldi H (2006) Economic evaluation of snake antivenom production in the public system. J Venom Anim Toxins Incl Trop Dis 12:497–511
Harms AJ (1948) The purification of antitoxic plasmas by enzyme treatment and heat denaturation. Biochem J 42:390–397
Boyer PD, Lum FG, Ballou GA et al (1946) The combination of fatty acids and related compounds with serum albumin. I. Stabilization against heat denaturation. J Biol Chem 162:181–198
Yu MW, Finlayson JS (1984) Stabilization of human albumin by caprylate and acetyltryptophanate. Vox Sang 47:28–40
Lebing W, Remington KM, Schreiner C et al (2003) Properties of a new intravenous immunoglobulin (IGIV-C, 10 %) produced by virus inactivation with caprylate and column chromatography. Vox Sang 84:193–201
Otero-Patiño R, Cardozo J, Higashi H et al (1998) A randomized, blinded, comparative trial of one pepsin-digested and two whole IgG antivenoms for Bothrops snake bites in Uraba, Colombia. Am J Trop Med Hyg 58:183–189
Otero-Patiño R, Gutierrez JM, Rojas G et al (1997) A randomized, blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites Colombia: correlation between safety and biochemical characteristics of antivenoms. Toxicon 37:895–908
Boyer PD, Ballou GA, Luck JM (1947) The combination of fatty acids and related compounds with serum albumin. III. The nature and extent of the combination. J Biol Chem 167:407–424
Van Oss CJ, Good RJ, Chaudhury MK (1986) Solubility of proteins. J Protein Chem 5:385–405
Morais V, Massaldi H (2012) A model mechanism for protein precipitation by caprylic acid: application to plasma purification. Biotechnol Appl Biochem 59:50–54
Harlow E, Lane D (1986) Antibodies. A laboratory manual. Cold Spring Harbor Laboratory, New York
Nudel BC, Perdoménico C, Iácono R et al (2012) Optimization by factorial analysis of caprylic acid precipitation of non-immunoglobulins from hyperimmune equine plasma for antivenom preparation. Toxicon 59:68–73
Gutiérrez JM, Rojas E, Quesada L et al (2005) Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa. Trans R Soc Trop Med Hyg 99:468–475
Herrera M, Meneses F, Gutiérrez JM et al (2009) Development and validation of a reverse phase HPLC method for the determination of caprylic acid in formulations of therapeutic immunoglobulins and its application to antivenom production. Biologicals 37:230–234
WHO (2010) WHO guidelines for the production, control and regulation of snake antivenom immunoglobulins. http://www.who.int/bloodproducts/snake_antivenoms/snakeantivenomguideline.pdf. Accessed 13 Feb 2013
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Morais, V., Berasain, P., Massaldi, H. (2014). Immunoglobulin Purification by Caprylic Acid. In: Labrou, N. (eds) Protein Downstream Processing. Methods in Molecular Biology, vol 1129. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-977-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-62703-977-2_13
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-976-5
Online ISBN: 978-1-62703-977-2
eBook Packages: Springer Protocols